These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14966582)

  • 1. [Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase in ameloblastoma].
    Zhong M; Han YP; Wang J; Li ZJ; Bao G; Yue YL
    Shanghai Kou Qiang Yi Xue; 2003 Dec; 12(6):427-31. PubMed ID: 14966582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The study of the invasive biologic behavior of ameloblastoma].
    Zhong M; Li ZJ; Wang J; Yue YL; Bao G
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Jan; 39(1):45-8. PubMed ID: 14989873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of ICAM-1 and VCAM-1 in human ameloblastoma and odontogenic keratocyst].
    Wang J; Zhong M; Zhang LZ; Wang Y; Wang ZY
    Shanghai Kou Qiang Yi Xue; 2003 Aug; 12(4):273-6. PubMed ID: 14966640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma].
    Guo W; Chen G; Zhu C; Wang H
    Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):604-7. PubMed ID: 12487935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of telomerase and p53 in ameloblastoma].
    Zhong M; Zhang LH; Wang J; Zhang B; Hou L
    Shanghai Kou Qiang Yi Xue; 2003 Apr; 12(2):127-31. PubMed ID: 14661519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis.
    Sanders JS; van Goor H; Hanemaaijer R; Kallenberg CG; Stegeman CA
    Nephrol Dial Transplant; 2004 Jun; 19(6):1412-9. PubMed ID: 15034162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.
    Zhang YG; DU J; Tian XX; Zhong YF; Fang WG
    Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The matrix metalloproteinase system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2006 Dec; 44(6):482-6. PubMed ID: 16338034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of osteonectin/secreted protein acidic and rich in cysteine and matrix metalloproteinases in ameloblastoma.
    Shen LC; Chen YK; Hsue SS; Shaw SY
    J Oral Pathol Med; 2010 Mar; 39(3):242-9. PubMed ID: 20070483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps.
    Chen YS; Langhammer T; Westhofen M; Lorenzen J
    Allergy; 2007 Jan; 62(1):66-72. PubMed ID: 17156344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
    Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
    Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and role of metalloproteinase-2 and endogenous tissue regulator in ameloblastoma.
    Zhang B; Zhang J; Huang HZ; Xu ZY; Xie HL
    J Oral Pathol Med; 2010 Mar; 39(3):219-22. PubMed ID: 19709349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The imbalanced expression of matrix metalloproteinases in nephrogenic systemic fibrosis.
    Kelly BC; Markle LS; Vickers JL; Petitt MS; Raimer SS; McNeese C
    J Am Acad Dermatol; 2010 Sep; 63(3):483-9. PubMed ID: 20708474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma.
    El-Shabrawi Y; Ardjomand N; Radner H; Ardjomand N
    J Pathol; 2001 Jun; 194(2):201-6. PubMed ID: 11400149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoexpression of MMPs-1, -2, and -9 in ameloblastoma and odontogenic adenomatoid tumor.
    Ribeiro BF; Iglesias DP; Nascimento GJ; Galvão HC; Medeiros AM; Freitas RA
    Oral Dis; 2009 Oct; 15(7):472-7. PubMed ID: 19522745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy.
    Bai SX; Wang YL; Qin L; Xiao ZJ; Herva R; Piao YS
    Reproduction; 2005 Jan; 129(1):103-13. PubMed ID: 15615902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.
    Brun JL; Cortez A; Commo F; Uzan S; Rouzier R; Daraï E
    Int J Oncol; 2008 Dec; 33(6):1239-46. PubMed ID: 19020757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
    de Vicente JC; Lequerica-Fernández P; Santamaría J; Fresno MF
    J Oral Pathol Med; 2007 Aug; 36(7):415-24. PubMed ID: 17617835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.